Instructure to Present at Upcoming Investor Conferences
Get Alerts INST Hot Sheet
Join SI Premium – FREE
- 19th Annual Needham Technology, Media & Consumer Conference. On
Thursday, May 16, 2024 , Chief Financial OfficerPeter Walker and Chief Strategy OfficerMitch Benson will virtually host a presentation at12:45 p.m. ET (10:45 a.m. MT ) and meet with investors. The webcast can be viewed here. And an archive of the webcast will be available for a limited time on Instructure's investor relations website under "Events & Presentations" at https://ir.instructure.com. - 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference. On
Tuesday, May 21, 2024 , Chief Executive OfficerSteve Daly and Chief Financial OfficerPeter Walker will present in-person at10:50 a.m. ET (8:50 a.m. MT ) and meet with investors inBoston, MA. The webcast can be viewed here. And an archive of the webcast will be available for a limited time on Instructure's investor relations website under "Events & Presentations" at https://ir.instructure.com.
About Instructure
Instructure is an education technology company dedicated to elevating student success, amplifying the power of teaching, and inspiring everyone to learn together. Today the Instructure Learning Platform, comprised of its flagship product Canvas LMS and several products serving K-12 and higher education, supports tens of millions of educators and learners around the world. Learn more at www.instructure.com.
Contacts
Corporate Communications
Instructure
(801) 610-9722
[email protected]
SVP of Investor Relations
Instructure
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/instructure-to-present-at-upcoming-investor-conferences-302141685.html
SOURCE Instructure Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Football Stars Missing This Summer's Cup Receive an Invitation from Ecuador
- Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
JPMorgan, Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share